Tech Company Financing Transactions

Fulcrum Therapeutics Funding Round

Fulcrum Therapeutics closed a $80 million Series B investment round on 9/6/2018. Investors included Foresite Capital, 6 Dimensions Capital and Casdin Capital.

Transaction Overview

Announced On
Transaction Type
Venture Equity
Series B
Proceeds Purpose
Proceeds from the financing will be used to advance Fulcrum's lead program in facioscapulohumeral muscular dystrophy (FSHD) into clinical testing, and to progress its pipeline of therapeutics for rare, genetically-based neuromuscular, central nervous system and hematologic disorders.

Company Information

Company Status
Mailing Address
26 Landsdowne St.
Cambridge, MA 02139
Email Address
Fulcrum Therapeutics (Nasdaq: FULC) is here to develop new medicines to deliver a new future for patients and their families by transforming gene regulation in disease. Above all we are champions for our patients. Trust, Respect, Compassion and Integrity define who we are.
Fulcrum Therapeutics LinkedIn Company Profile
Social Media
Fulcrum Therapeutics Company Twitter Account
Company News
Fulcrum Therapeutics News
Fulcrum Therapeutics on Facebook
Fulcrum Therapeutics on YouTube

Management Team

Email & Social
Chief Executive Officer
Robert Gould
  Robert Gould LinkedIn Profile  Robert Gould Twitter Account  Robert Gould News  Robert Gould on Facebook
Chief Scientific Officer
Owen Wallace
  Owen Wallace LinkedIn Profile  Owen Wallace Twitter Account  Owen Wallace News  Owen Wallace on Facebook
Vice President
Diego Cadavid
  Diego Cadavid LinkedIn Profile  Diego Cadavid Twitter Account  Diego Cadavid News  Diego Cadavid on Facebook
Vice President
Lucienne Ronco
  Lucienne Ronco LinkedIn Profile  Lucienne Ronco Twitter Account  Lucienne Ronco News  Lucienne Ronco on Facebook
VP - Finance
Peter Thomson
  Peter Thomson LinkedIn Profile  Peter Thomson Twitter Account  Peter Thomson News  Peter Thomson on Facebook
VP - Human Resources
Kim Hazen
  Kim Hazen LinkedIn Profile  Kim Hazen Twitter Account  Kim Hazen News  Kim Hazen on Facebook



Browse more venture capital transactions:

Prev: 9/6/2018: SpotHero venture capital transaction
Next: 9/6/2018: Yoco venture capital transaction


Share this article


Where The Data Comes From

Our team works diligently to report on every notable VC transaction. VC investment data records reported here are sourced from news reports and company announcements. The data comes to us via our partnership with, an affiliated venture.


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities


Business Glossary